Premium
Malignant lymphomas of the pharynx
Author(s) -
AlSaleem Tahseen,
Harwick Robert,
Robbins Robert,
Blady John V.
Publication year - 1970
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(197012)26:6<1383::aid-cncr2820260631>3.0.co;2-i
Subject(s) - medicine , pharynx , radiation therapy , lymphoma , cervical lymph nodes , lymph , pathology , chemotherapy , follicular lymphoma , sarcoma , cancer , radiology , surgery , metastasis
Fifty‐five patients with malignant lymphoma of the pharynx were studied, and the pathologic material was analyzed. It is concluded that reticulum cell sarcoma with no involvement of the cervical lymph nodes is a highly curable tumor by radiotherapy (7 out of 9 survived 5 years or more). On the other hand, almost all the patients with involvement of the cervical lymph nodes had early recurrences or metastases that failed to respond to various therapeutic measures. Well‐differentiated lymphocytic lymphoma (lymphosarcoma) showed more tendency to disseminate, but recurrences were relatively easier to control by radiotherapy or chemotherapy and compatible with long survival. As expected, all 3 patients with nodular lymphoma (giant follicular lymphoma) are living 5 years or more and only one with disseminated disease. Hodgkin's disease is rare in the pharynx. Careful histologic classification and irradiation to eradicate the tumor are extremely useful measures in controlling these neoplasms.